Skip to content

Effects of subanesthetic doses of esketamine on postoperative pain and early recovery in patients undergoing abdominal surgery

Effects of subanesthetic doses of esketamine on postoperative pain and early recovery in patients undergoing abdominal surgery

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200062921
Enrollment
Unknown
Registered
2022-08-24
Start date
2022-08-24
Completion date
Unknown
Last updated
2023-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative pain

Interventions

Intervention group 1 :0.1mg/kg/h Esketamine
Intervention group 2:0.2mg/kg/h Esketamine
Intervention group 3:0.3mg/kg/h Esketamine

Sponsors

Affiliated Cancer Hospital of Guizhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: A, age: 18-65 years old b, ASA:I III c, BMI (kg/m2): 18-30 d, patients who intend to undergo abdominal surgery under general anesthesia and the expected operation time is 2 hours to 4 hours; e, informed consent has been signed

Exclusion criteria

Exclusion criteria: a, patients with mental illness; b, patients with severe risk of elevated blood pressure or intracranial pressure; c, patients with high intraocular pressure, glaucoma or penetrating ocular trauma; d, patients with poorly controlled or untreated hypertension, patients with resting systolic / diastolic blood pressure more than 180mm Hg e, patients with hyperthyroidism without treatment or insufficient treatment; f, patients with hypersensitivity to ketamine, propofol and opioids. g, patients with unstable ischemic heart disease; h, patients with cardiac insufficiency (NYHA cardiac function grade >= 3), previous cerebral infarction, severe liver disease (such as liver failure) or chronic renal failure (glomerular filtration rate < 30ml/min); i, have participated in other clinical trials

Design outcomes

Primary

MeasureTime frame
24 hours after operation, the resting state and the proportion of moderate and severe pain during exercise.;

Secondary

MeasureTime frame
the time of extubation of endotracheal tube, the time of awakening from anesthesia and the time of leaving the operating room;Intraoperative opioid dose;Adverse reactions of opioids within 3 days after operation;the time of recovery of gastrointestinal function after operation;Time to get out of bed for the first time after operation; 24-hour postoperative recovery quality scale score (QoR-15);postoperative hospital stay (days) and total hospitalization cost;

Countries

china

Contacts

Public Contactyiqianglin
691206869@qq.com13595056784

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026